Shanghai Pharmaceutical announced that the marketing application for perindopril tert-butylamine as an API was approved.
上海医药：培哚普利叔丁胺原料药上市申请获得批准
Shanghai Pharmaceutical: Application for marketing of perindopril tert-butylamine API approved
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.